Kim YH - Search Results

1

Immunohistochemical expression of BCRP and ERCC1 in biopsy specimen predicts survival in advanced non-small-cell lung cancer treated with cisplatin-based chemotherapy.

Ota S, Ishii G, Goto K, Kubota K, Kim YH, Kojika M, Murata Y, Yamazaki M, Nishiwaki Y, Eguchi K, Ochiai A. Ota S, et al. Among authors: kim yh. Lung Cancer. 2009 Apr;64(1):98-104. doi: 10.1016/j.lungcan.2008.07.014. Epub 2008 Sep 26. Lung Cancer. 2009. PMID: 18823676

2

Dominant papillary subtype is a significant predictor of the response to gefitinib in adenocarcinoma of the lung.

Kim YH, Ishii G, Goto K, Nagai K, Tsuta K, Shiono S, Nitadori J, Kodama T, Nishiwaki Y, Ochiai A. Kim YH, et al. Clin Cancer Res. 2004 Nov 1;10(21):7311-7. doi: 10.1158/1078-0432.CCR-04-0811. Clin Cancer Res. 2004. PMID: 15534107

3

Predictive factors for local recurrence of resected colorectal lung metastases.

Shiono S, Ishii G, Nagai K, Yoshida J, Nishimura M, Murata Y, Tsuta K, Kim YH, Nishiwaki Y, Kodama T, Iwasaki M, Ochiai A. Shiono S, et al. Among authors: kim yh. Ann Thorac Surg. 2005 Sep;80(3):1040-5. doi: 10.1016/j.athoracsur.2004.12.033. Ann Thorac Surg. 2005. PMID: 16122482

4

Interstitial shadow on chest CT is associated with the onset of interstitial lung disease caused by chemotherapeutic drugs.

Niho S, Goto K, Yoh K, Kim YH, Ohmatsu H, Kubota K, Saijo N, Nishiwaki Y. Niho S, et al. Among authors: kim yh. Jpn J Clin Oncol. 2006 May;36(5):269-73. doi: 10.1093/jjco/hyl021. Epub 2006 May 15. Jpn J Clin Oncol. 2006. PMID: 16702163

5

[A resected case of sclerosing thymoma].

Kim YH, Ishii G, Naito Y, Goto K, Nagai K, Nishiwaki Y. Kim YH, et al. Nihon Kokyuki Gakkai Zasshi. 2006 May;44(5):420-3. Nihon Kokyuki Gakkai Zasshi. 2006. PMID: 16780103 Japanese.

6

Performance status and sensitivity to first-line chemotherapy are significant prognostic factors in patients with recurrent small cell lung cancer receiving second-line chemotherapy.

Kim YH, Goto K, Yoh K, Niho S, Ohmatsu H, Kubota K, Saijo N, Nishiwaki Y. Kim YH, et al. Cancer. 2008 Nov 1;113(9):2518-23. doi: 10.1002/cncr.23871. Cancer. 2008. PMID: 18780323 Free article.

7

Expression of breast cancer resistance protein is associated with a poor clinical outcome in patients with small-cell lung cancer.

Kim YH, Ishii G, Goto K, Ota S, Kubota K, Murata Y, Mishima M, Saijo N, Nishiwaki Y, Ochiai A. Kim YH, et al. Lung Cancer. 2009 Jul;65(1):105-11. doi: 10.1016/j.lungcan.2008.10.008. Epub 2008 Nov 25. Lung Cancer. 2009. PMID: 19036469 Free article.

8

A phase I study of gemcitabine and carboplatin in patients with advanced non-small cell lung cancer and a performance status of 2.

Kim YH, Kubota K, Goto K, Yoh K, Niho S, Ohmatsu H, Saijo N, Nishiwaki Y. Kim YH, et al. Jpn J Clin Oncol. 2009 Sep;39(9):576-81. doi: 10.1093/jjco/hyp061. Epub 2009 Jun 11. Jpn J Clin Oncol. 2009. PMID: 19520688 Clinical Trial.

9

Trends in chemotherapy for elderly patients with advanced non-small-cell lung cancer.

Kim YH, Yoh K, Niho S, Goto K, Ohmatsu H, Kubota K, Nishiwaki Y. Kim YH, et al. Respir Med. 2010 Mar;104(3):434-9. doi: 10.1016/j.rmed.2009.10.020. Epub 2009 Nov 12. Respir Med. 2010. PMID: 19913397 Free article.

10

Re-challenge chemotherapy for relapsed non-small-cell lung cancer.

Nagano T, Kim YH, Goto K, Kubota K, Ohmatsu H, Niho S, Yoh K, Naito Y, Saijo N, Nishiwaki Y. Nagano T, et al. Among authors: kim yh. Lung Cancer. 2010 Sep;69(3):315-8. doi: 10.1016/j.lungcan.2009.11.016. Epub 2010 Jan 13. Lung Cancer. 2010. PMID: 20071052

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

12,454 results

Search Page